Physician profile
James E Clinton
NPI 1558340356
$1,752.19
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $513 · 2021: $456.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $432.62 | 2019-2021 | |
| Novo Nordisk INC | $384.58 | 2019-2021 | |
| Lilly USA, LLC | $191.29 | 2019-2021 | |
| Abbvie INC. | $142.58 | 2021 | |
| Glaxosmithkline, LLC. | $108.65 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $99.46 | 2019-2020 | |
| Mylan Specialty L.P. | $90.81 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.78 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $39.17 | 2019-2020 | |
| Pfizer INC. | $38.63 | 2019-2021 | |
| Allergan, INC. | $33.39 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.40 | 2019 | |
| Astellas Pharma US INC | $23.96 | 2019 | |
| Radius Health, INC. | $15.80 | 2020 | |
| Valeritas, INC. | $15.72 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.35 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Clinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.